Eam Investors, LLC Actinium Pharmaceuticals, Inc. Transaction History
Eam Investors, LLC
- $616 Million
- Q4 2024
Shares
1 transactions
Others Institutions Holding ATNM
# of Institutions
70Shares Held
7.94MCall Options Held
59.6KPut Options Held
4.8K-
Black Rock Inc. New York, NY1.88MShares$3.75 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.62MShares$3.23 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$1.38 Million0.0% of portfolio
-
State Street Corp Boston, MA621KShares$1.24 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA499KShares$998,5200.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $50.4M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...